{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:29:08Z","timestamp":1783434548066,"version":"3.54.6"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alzheimer\u2019s disease (AD) is characterized by the accumulation of amyloid-beta (A\u03b2) in the brain, which begins decades before the appearance of clinical symptoms. Blood from AD patients, when spiked with synthetic A\u03b2, exhibited a higher A\u03b2 oligomerization tendency (OA\u03b2T) than the non-AD subjects. OA\u03b2T reflected early pathological changes of AD and is considered as a promising blood-based biomarker. However, the mechanism underlying OA\u03b2T remained elusive. This study aimed to identify proteomic signatures associated with OA\u03b2T and explore its role in AD diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Forty AD and non-AD subjects from a Korean cohort were divided into four groups based on the disease diagnosis, OA\u03b2T values (thresholded at 0.78\u202fng\/mL), and amyloid PET status (A-PET): A-PET-positive AD patients with high or low OA\u03b2T values, A-PET-negative non-AD subjects with high or low OA\u03b2T values. Using aptamer-based proteomics, 7,288 proteins from plasma samples were quantified, and the group differences were assessed in protein levels and the enrichment of gene sets associated with annotations from the Gene Ontology database. Further, we assessed whether OA\u03b2T-PET mismatched cases (A-PET-positive but OA\u03b2T-low or A-PET-negative but OA\u03b2T-high) exhibited distinct blood proteome signatures in comparison to typical AD cases. Aging signatures for 11 organs were analyzed to explore systemic factors linked to OA\u03b2T-PET discrepancies. Additionally, the pharmacological influences on the OA\u03b2T-related proteome were investigated by comparing OA\u03b2T-correlated proteins with a database of drug-induced proteomic changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Elevated OA\u03b2T values, regardless of AD diagnosis, correlated with increased immune response and decreased cellular metabolism. Dementia-predicting proteins were enriched in non-AD individuals with high OA\u03b2T. Accelerated muscle aging was associated with high OA\u03b2T values and worse cognitive function. Furthermore, several potential pharmacological modulators of OA\u03b2T, including Minocycline and Anamorelin, were identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings demonstrated OA\u03b2T as a reflection of systemic changes linked to early AD pathology. Moreover, the influence of medications and systemic aging on OA\u03b2T values pointed to the potential avenues for intervention and emphasized the importance of considering systemic factors in AD pathogenesis and treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2026.1620991","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:44:53Z","timestamp":1774266293000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Systemic proteomic and organ aging signatures associated with plasma A\u03b2 oligomerization in a Korean cohort: a cross-sectional study"],"prefix":"10.3389","volume":"18","author":[{"given":"Hyunjung","family":"Oh","sequence":"first","affiliation":[{"name":"PeopleBio Inc.","place":["Seongnam-si, Gyeonggi-do, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongju","family":"Kim","sequence":"additional","affiliation":[{"name":"PeopleBio Inc.","place":["Seongnam-si, Gyeonggi-do, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojin","family":"Kang","sequence":"additional","affiliation":[{"name":"PeopleBio Inc.","place":["Seongnam-si, Gyeonggi-do, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dohyeon","family":"Kwon","sequence":"additional","affiliation":[{"name":"PeopleBio Inc.","place":["Seongnam-si, Gyeonggi-do, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"French","sequence":"additional","affiliation":[{"name":"Physiology Department and Donnelly Centre for Cellular and Biomolecular Research, University of Toronto","place":["Toronto, ON, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ho","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Neurology, Seoul National University Bundang Hospital and Seoul National University College of Medicine","place":["Seongnam-si, Gyeonggi-do, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Chul","family":"Youn","sequence":"additional","affiliation":[{"name":"Department of Neurology, Chung-Ang University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Soo","family":"An","sequence":"additional","affiliation":[{"name":"Department of BionanoTechnology, Gachon University","place":["Seongnam-si, Gyeonggi-do, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SangYun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Seoul National University Bundang Hospital and Seoul National University College of Medicine","place":["Seongnam-si, Gyeonggi-do, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungmin","family":"Kang","sequence":"additional","affiliation":[{"name":"PeopleBio Inc.","place":["Seongnam-si, Gyeonggi-do, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"21812","DOI":"10.1073\/pnas.1010373107","article-title":"Alzheimer's disease peptide \u03b2-amyloid interacts with fibrinogen and induces its oligomerization","volume":"107","author":"Ahn","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"26759","DOI":"10.1038\/srep26759","article-title":"Vitamin k3 inhibits protein aggregation: implication in the treatment of amyloid diseases","volume":"6","author":"Alam","year":"2016","journal-title":"Sci. Rep."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13195-017-0310-6","article-title":"Dynamic changes of oligomeric amyloid beta levels in plasma induced by spiked synthetic Abeta(42)","volume":"9","author":"An","year":"2017","journal-title":"Alzheimer's Res. Ther."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/archneur.61.5.661","article-title":"Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function","volume":"61","author":"Arvanitakis","year":"2004","journal-title":"Arch. Neurol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-021-00822-3","article-title":"Plasma amyloid-\u03b2 oligomerization assay as a pre-screening test for amyloid status","volume":"13","author":"Babapour Mofrad","year":"2021","journal-title":"Alzheimer's Res. Ther."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic A\u03b2 oligomer and Alzheimer's disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat. Neurosci."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/JAD-160611","article-title":"Efficacy and safety of plasma exchange with 5% albumin to modify cerebrospinal fluid and plasma amyloid-\u03b2 concentrations and cognition outcomes in Alzheimer\u2019s disease patients: a multicenter, randomized, controlled clinical trial","volume":"56","author":"Boada","year":"2017","journal-title":"J. Alzheimer's Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/alz.12493","article-title":"Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study","volume":"18","author":"Boada","year":"2022","journal-title":"Alzheimers Dement."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jmb.2018.01.028","article-title":"Serum albumin's protective inhibition of amyloid-\u03b2 fiber formation is suppressed by cholesterol, fatty acids and warfarin","volume":"430","author":"Bode","year":"2018","journal-title":"J. Mol. Biol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"14742","DOI":"10.1074\/jbc.270.24.14742","article-title":"Carbonic anhydrase iii. Oxidative modification in vivo and loss of phosphatase activity during aging\u2217","volume":"270","author":"Cabiscol","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e0136528","DOI":"10.1371\/journal.pone.0136528","article-title":"Unraveling comparative anti-amyloidogenic behavior of pyrazinamide and D-cycloserine: a mechanistic biophysical insight","volume":"10","author":"Chaturvedi","year":"2015","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"103588","DOI":"10.1016\/j.mcn.2021.103588","article-title":"Endogenous A\u03b2 peptide promote A\u03b2 oligomerization tendency of spiked synthetic A\u03b2 in Alzheimer's disease plasma","volume":"111","author":"Choi","year":"2021","journal-title":"Mol. Cell. Neurosci."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"S567","DOI":"10.3233\/JAD-179941","article-title":"The amyloid-\u03b2 oligomer hypothesis: beginning of the third decade","volume":"64","author":"Cline","year":"2018","journal-title":"J. Alzheimer's Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.nbd.2014.05.001","article-title":"Early detection of Alzheimer's disease using PiB and FDG PET","volume":"72","author":"Cohen","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13195-022-01113-5","article-title":"Multi-platform proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome","volume":"14","author":"Dammer","year":"2022","journal-title":"Alzheimer's Res. Ther."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.2174\/138161208784480171","article-title":"The role of the cell surface LRP and soluble LRP in blood-brain barrier A\u03b2 clearance in Alzheimer's disease","volume":"14","author":"Deane","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1515\/hsz-2014-0152","article-title":"Immune-modulating effects of alpha-1 antitrypsin","volume":"395","author":"Ehlers","year":"2014","journal-title":"Biol. Chem."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"13033","DOI":"10.1074\/jbc.M110.184770","article-title":"Recognition of the major cat allergen Fel d 1 through the cysteine-rich domain of the mannose receptor determines its allergenicity","volume":"286","author":"Emara","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/1073858410397054","article-title":"The aging hippocampus: interactions between exercise, depression, and BDNF","volume":"18","author":"Erickson","year":"2012","journal-title":"Neuroscientist"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"983","DOI":"10.4103\/1673-5374.233438","article-title":"Natural polyphenols effects on protein aggregates in Alzheimer's and Parkinson's prion-like diseases","volume":"13","author":"Freyssin","year":"2018","journal-title":"Neural Regen. Res."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1126587","DOI":"10.3389\/fnagi.2023.1126587","article-title":"Dementia incidence and population-attributable fraction for dementia risk factors in Republic of Korea: a 12-year longitudinal follow-up study of a national cohort","volume":"15","author":"Hwangbo","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1056\/NEJMoa2309821","article-title":"Biomarker changes during 20 years preceding Alzheimer\u2019s disease","volume":"390","author":"Jia","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/alz.12368","article-title":"Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer's disease screening and staging","volume":"18","author":"Jiang","year":"2022","journal-title":"Alzheimers Dement."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1038\/tp.2012.45","article-title":"Genome-wide association study of Alzheimer's disease","volume":"2","author":"Kamboh","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1007\/s11357-022-00601-4","article-title":"Old plasma dilution reduces human biological age: a clinical study","volume":"44","author":"Kim","year":"2022","journal-title":"Geroscience"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13195-022-01105-5","article-title":"Plasma amyloid-beta oligomer is related to subjective cognitive decline and brain amyloid status","volume":"14","author":"Kim","year":"2022","journal-title":"Alzheimer's Res. Ther."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1002\/alz.14054","article-title":"Development of a prediction model for cognitive impairment of sarcopenia using multimodal neuroimaging in non-demented older adults","volume":"20","author":"Kim","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0014-5793(96)01457-6","article-title":"Murine tissue inhibitor of metalloproteinases\u20144 (Timp\u20144): cDNA isolation and expression in adult mouse tissues 1","volume":"401","author":"Leco","year":"1997","journal-title":"FEBS Lett."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ana.25968","article-title":"Diagnostic accuracy of amyloid versus 18F-fluorodeoxyglucose positron emission tomography in autopsy-confirmed dementia","volume":"89","author":"Lesman-Segev","year":"2021","journal-title":"Ann. Neurol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/alz.12419","article-title":"Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and atherosclerosis risk in communities studies","volume":"18","author":"Lindbohm","year":"2022","journal-title":"Alzheimers Dement."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00210-021-02140-3","article-title":"Metalloproteinases and their inhibitors in neurological disease","volume":"395","author":"Lopez-Navarro","year":"2022","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1189\/jlb.0512231","article-title":"The mannose receptor","volume":"92","author":"Martinez-Pomares","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1802.03426","DOI":"10.48550\/arXiv.1802.03426","article-title":"Umap: uniform manifold approximation and projection for dimension reduction","author":"McInnes","year":"2018","journal-title":"arXiv preprint arXiv"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11357-020-00289-x","article-title":"Plasma dilution improves cognition and attenuates neuroinflammation in old mice","volume":"43","author":"Mehdipour","year":"2021","journal-title":"Geroscience"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"8790","DOI":"10.18632\/aging.103418","article-title":"Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin","volume":"12","author":"Mehdipour","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-019-0535-7","article-title":"Association between increased levels of amyloid-\u03b2 oligomers in plasma and episodic memory loss in Alzheimer\u2019s disease","volume":"11","author":"Meng","year":"2019","journal-title":"Alzheimer's Res. Ther."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e13984","DOI":"10.1371\/journal.pone.0013984","article-title":"Enrichment map: a network-based method for gene-set enrichment visualization and interpretation","volume":"5","author":"Merico","year":"2010","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41587-023-01684-6","article-title":"A proteome-wide atlas of drug mechanism of action","volume":"41","author":"Mitchell","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1007\/s10072-018-3464-6","article-title":"Muscle profile and cognition in patients with Alzheimer\u2019s disease dementia","volume":"39","author":"Moon","year":"2018","journal-title":"Neurol. Sci."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-020-01035-2","article-title":"Infusion of blood from mice displaying cerebral amyloidosis accelerates amyloid pathology in animal models of Alzheimer\u2019s disease","volume":"8","author":"Morales","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.bbadis.2014.04.012","article-title":"Is Alzheimer's disease a systemic disease?","volume":"1842","author":"Morris","year":"2014","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat. Med."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41586-023-06802-1","article-title":"Organ aging signatures in the plasma proteome track health and disease","volume":"624","author":"Oh","year":"2023","journal-title":"Nature"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"S499","DOI":"10.1007\/s00011-007-6221-5","article-title":"Kallikrein-mediated activation of PARs in inflammation and nociception","volume":"56","author":"Oikonomopoulou","year":"2007","journal-title":"Inflamm. Res."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2147\/CIA.S304798","article-title":"Plasma amyloid-\u03b2 oligomerization tendency predicts amyloid PET positivity","author":"Pyun","year":"2021","journal-title":"Clin. Interv. Aging"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1038\/ncomms13363","article-title":"A single heterochronic blood exchange reveals rapid inhibition of multiple tissues by old blood","volume":"7","author":"Rebo","year":"2016","journal-title":"Nat. Commun."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1038\/mtna.2014.49","article-title":"Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents","volume":"3","author":"Rohloff","year":"2014","journal-title":"Molecular Therapy-Nucleic Acids"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/j.1742-4658.2010.07568.x","article-title":"Amyloid oligomers: formation and toxicity of a\u03b2 oligomers","volume":"277","author":"Sakono","year":"2010","journal-title":"FEBS J."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"16","DOI":"10.17912\/micropub.biology.000811","article-title":"Rrvgo: a Bioconductor package for interpreting lists of gene ontology terms","volume":"2023","author":"Sayols","year":"2023","journal-title":"MicroPubl Biol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3233\/JAD-190815","article-title":"A narrative review of handgrip strength and cognitive functioning: bringing a new characteristic to muscle memory","volume":"73","author":"Shaughnessy","year":"2020","journal-title":"J. Alzheimer's Dis"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.jalz.2019.06.4951","article-title":"Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay","volume":"15","author":"Shi","year":"2019","journal-title":"Alzheimers Dement."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1038\/s41380-022-01576-6","article-title":"Preventive and therapeutic reduction of amyloid deposition and behavioral impairments in a model of Alzheimer\u2019s disease by whole blood exchange","volume":"27","author":"Urayama","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature10357","article-title":"The ageing systemic milieu negatively regulates neurogenesis and cognitive function","volume":"477","author":"Villeda","year":"2011","journal-title":"Nature"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"The Lan. Neurol."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3233\/JAD-150020","article-title":"Blood protein markers of neocortical amyloid-\u03b2 burden: a candidate study using SOMAscan technology","volume":"46","author":"Voyle","year":"2015","journal-title":"J. Alzheimer's Dis"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s43587-021-00064-0","article-title":"Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk","volume":"1","author":"Walker","year":"2021","journal-title":"Nature Aging"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13195-024-01374-3","article-title":"Plasma oligomer amyloid-betais associated with disease severity and cerebral amyloid deposition in Alzheimer\u2019s disease spectrum","volume":"16","author":"Wang","year":"2024","journal-title":"Alzheimer's Res. Ther."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3233\/JAD-170786","article-title":"Medical comorbidity in Alzheimer\u2019s disease: a nested case-control study","volume":"63","author":"Wang","year":"2018","journal-title":"J. Alzheimer's Dis"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13195-017-0324-0","article-title":"Oligomeric forms of amyloid-\u03b2 protein in plasma as a potential blood-based biomarker for Alzheimer\u2019s disease","volume":"9","author":"Wang","year":"2017","journal-title":"Alzheimer's Res. Ther."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","article-title":"Midlife cardiovascular risk factors and risk of dementia in late life","volume":"64","author":"Whitmer","year":"2005","journal-title":"Neurology"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"e70064","DOI":"10.1002\/dad2.70064","article-title":"Plasma amyloid-\u03b2 oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: findings from the GMCII cohort","volume":"17","author":"Xie","year":"2025","journal-title":"Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"530219","DOI":"10.3389\/fnins.2020.530219","article-title":"Metabolic dysregulation contributes to the progression of Alzheimer\u2019s disease","volume":"14","author":"Yan","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13195-019-0499-7","article-title":"Blood amyloid-beta oligomerization associated with neurodegeneration of Alzheimer's disease","volume":"11","author":"Youn","year":"2019","journal-title":"Alzheimer's Res. Ther."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JAD-200061","article-title":"Blood amyloid-\u03b2 oligomerization as a biomarker of Alzheimer\u2019s disease: a blinded validation study","volume":"75","author":"Youn","year":"2020","journal-title":"J. Alzheimer's Dis"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/s41591-019-0434-3","article-title":"Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1","volume":"25","author":"Yousef","year":"2019","journal-title":"Nat. Med."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1620991\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:44:55Z","timestamp":1774266295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1620991\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":66,"alternative-id":["10.3389\/fnagi.2026.1620991"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1620991","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"article-number":"1620991"}}